SHINE 2Europe and Horizon Europe project RadioVal were featured on issue #18 of the newsletter of ANI – National Agency of Innovation 
SHINE 2Europe participates in the project “RadioVal- International Clinical Validation of Radiomics Artificial Intelligence for Breast Cancer Treatment Planning”, coordinated by the Universitat de Barcelona, that aims to carry out a clinical validation of the estimation of radiomic-guided adjuvant chemotherapy in the response to breast cancer. 
SHINE will coordinate the Social Innovation methodology to involve citizens, professionals, patients, public authorities and other relevant actors in the evaluation and implementation of radiomics and Artificial Intelligence tools in the treatment of breast cancer. 
It will also lead the impact assessment process with regard specifically to potential socio-ethical implications, considering the diversity of contexts between countries and populations. 
Get to know all about RadioVal project on the website: https://radioval.eu/